TriMas Corporation 2023 Form 10-K Summary
Business context and reporting period
TriMas designs and manufactures engineered products for consumer products, aerospace and defense, and industrial markets through three segments: Packaging, Aerospace, and Specialty Products. The filing covers the fiscal year ended December 31, 2023; it is an annual report, not a standalone fourth-quarter filing. TriMas had approximately 3,400 employees, 38 manufacturing and support locations in 13 countries, and generated approximately 72% of sales in North America.
Financial performance and key metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Net sales | $893.6 million | $883.8 million | Up 1.1% |
| Gross profit | $201.3 million | $208.3 million | Down 3.4% |
| Gross margin | 22.5% | 23.6% | Down 110 bps |
| Operating profit | $65.4 million | $99.1 million | Down 33.9% |
| Operating margin | 7.3% | 11.2% | Down 390 bps |
| Net income | $40.4 million | $66.2 million | Down 39.0% |
| Diluted EPS | $0.97 | $1.56 | Down $0.59 |
| Cash flow from operations | $88.2 million | $72.6 million | Up $15.6 million |
| Capital expenditures | $54.2 million | $46.0 million | Up $8.2 million |
Segment sales and operating profit were: Packaging sales of $463.6 million and operating profit of $60.1 million; Aerospace sales of $241.4 million and operating profit of $15.5 million; and Specialty Products sales of $188.6 million and operating profit of $36.4 million.
At December 31, 2023, cash and cash equivalents were $34.9 million, accounts receivable were $148.0 million, and inventories were $192.5 million. Total assets were $1.34 billion and shareholders’ equity was $683.0 million.
Long-term debt, net of issuance costs, was $395.7 million, consisting primarily of $400.0 million of 4.125% senior notes due April 2029. No amounts were outstanding under the $300.0 million revolving credit facility; $294.0 million was available before leverage restrictions and $256.9 million was available for general corporate purposes after those restrictions. Actual total net leverage was 2.39x versus a 4.00x covenant limit, and interest coverage was 11.13x versus a 3.00x requirement. The company was in compliance with its debt covenants.
TriMas paid $6.7 million in dividends and repurchased $18.8 million of common stock during 2023. The company had $86.9 million remaining under its repurchase authorization at year-end. Quarterly dividends remained $0.04 per share.
Material changes versus the prior comparable period
- Packaging sales declined 11.2% and operating profit declined 25.8%, primarily because customers reduced orders while rebalancing elevated inventories and managing inflation-related uncertainty.
- Aerospace sales increased 28.3% and operating profit increased to $15.5 million, supported by stronger aircraft production demand, improved throughput, and the Weldmac acquisition.
- Specialty Products sales increased 8.6% and operating profit increased 20.3%, helped by stronger cylinder demand, pricing, and first-half demand for engines and compressors.
- Acquisitions contributed $55.5 million of sales growth: $23.6 million from Aarts Packaging, $26.6 million from Weldmac, and $5.3 million from the 2022 Intertech acquisition during the comparable period.
- Pre-tax realignment charges increased to $10.3 million from $5.0 million, primarily for consolidating two China facilities and closing the Rohnert Park, California facility.
- 2022 included $22.4 million of gains from the sale of non-core properties, which did not recur in 2023. Corporate expenses consequently increased to $46.6 million from $20.3 million.
- Interest expense increased to $15.9 million from $14.1 million because of higher effective interest rates and average borrowings. The effective tax rate declined to 20.2% from 24.5%.
Guidance, outlook, risks, contingencies, and unusual items
Management expects a gradual recovery in consumer products and industrial markets in 2024, with consumer spending improving earlier in the year, while aerospace and defense demand is expected to remain strong. Management plans to increase aerospace capacity, improve manufacturing throughput, continue footprint and cost actions, pursue acquisitions, and maintain dividends and share repurchases subject to market conditions.
Key risks include uncertain customer demand, cyclical industrial and aerospace markets, inflation in wages and materials, supply-chain disruption, tariffs and geopolitical tensions, foreign currency volatility, customer concentration, labor availability and potential work stoppages, cybersecurity incidents, and execution risk related to acquisitions and facility consolidations.
The company has initiated a sales process for Arrow Engine, which would reduce its exposure to the oil and gas end market. The filing does not provide a completion date or expected sale proceeds.
Goodwill and other intangible assets totaled $544.8 million, or 40.6% of total assets. No goodwill impairment was recorded, but TriMas recorded a $1.1 million impairment charge for an aerospace-related trade name. The company also recorded a $2.4 million non-cash Weldmac inventory purchase-accounting charge.
TriMas retained asbestos-related liabilities from its former Lamons business. At year-end, 4,863 claimants were pending across 459 cases, and the recorded asbestos liability was $26.6 million. Historical settlement costs totaled $13.1 million, and management stated that the matters were not expected to have a material adverse effect, although future claims and defense costs remain uncertain.
Management and Deloitte concluded that internal controls over financial reporting were effective. However, the assessment excluded Aarts and Weldmac, acquired in 2023, which together contributed $50.2 million of 2023 sales and had $98.7 million of year-end assets.
Most important facts for investors to verify
- Whether Packaging demand and margins recover after the 2023 inventory correction, and whether the facility consolidations deliver expected savings.
- Whether Aerospace growth and Weldmac integration offset continued wage, material, and capacity pressures.
- Progress, valuation, and proceeds from the planned Arrow Engine sale.
- Cash conversion after $54.2 million of capital expenditures, acquisitions, dividends, and share repurchases.
- Debt refinancing and liquidity planning before the March 2026 revolving facility maturity and the April 2029 senior-note maturity.
- Potential goodwill, intangible-asset, and fixed-asset impairments if demand or operating profit deteriorates.
- Changes in asbestos claims, recorded reserves, defense costs, and the availability of excess insurance coverage.
- Whether the expected 2024 market recovery and continued aerospace strength materialize amid macroeconomic, geopolitical, tariff, and supply-chain uncertainty.